Trial Profile
Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Sep 2021
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 20 Sep 2021 Planned End Date changed from 8 Oct 2024 to 8 Oct 2025.
- 20 Sep 2021 Planned primary completion date changed from 8 Oct 2022 to 8 Oct 2023.
- 10 Aug 2020 Planned End Date changed from 8 Oct 2023 to 8 Oct 2024.